The Oregon Clinic Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2000
NCT00139633
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Oregon Clinic, Portland, OR

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophageal Neoplasms (Phase 2)

Mycobacterium avium-intracellulare Infection (Phase 3)

Mycobacterium Infections (Phase 3)

Mycobacterium Infections, Nontuberculous (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7